Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases

Frontiers in Cellular Neuroscience

Volumn 9, Issue APR, 2015, Pages

  Chin Chan, Miguel ^a   Navarro Yepes, Juliana ^a   Quintanilla Vega, Betzabet ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Alpha synuclein; Alzheimer s diseases; Beta amyloid; Metals; Neurodegenerative disorders; Parkinson s disease; Pesticides; Tau protein

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALPHA SYNUCLEIN; ALUMINUM; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; CADMIUM; DNA METHYLTRANSFERASE; ENDOTHELIN CONVERTING ENZYME; LEAD; MERCURY; NANOPARTICLE; PESTICIDE; PROTEIN AGGREGATE; REACTIVE OXYGEN METABOLITE; TAU PROTEIN; TRICHLOROETHYLENE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; DIET; DISEASE PREDISPOSITION; DNA DAMAGE; ENCEPHALITIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; HUMAN; LEWY BODY; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; POLLUTANT; POLLUTION; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN PHOSPHORYLATION; RISK FACTOR;

EID: 84927610673     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00124     Document Type: Article

References (266)

1. Abbott, R. D., Ross, G. W., Tanner, C. M., Andersen, J. K., Masaki, K. H., Rodriguez, B. L., et al. (2012). Late-life hemoglobin and the incidence of Parkinson's disease. Neurobiol. Aging 33, 914-920. doi: 10.1016/j.neurobiolaging.2010.06.023
2. Altmann, P., Cunningham, J., Dhanesha, U., Ballard, M., Thompson, J., and Marsh, F. (1999). Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident. BMJ 319, 807-811. doi: 10.1136/bmj.319.7213.807
3. Alvarez, Y. D., Fauerbach, J. A., Pellegrotti, J. V., Jovin, T. M., Jares-Erijman, E. A., and Stefani, F. D. (2013). Influence of gold nanoparticles on the kinetics of alpha-synuclein aggregation. Nano Lett. 13, 6156-6163. doi: 10.1021/nl403490e
4. An, L., Liu, S., Yang, Z., and Zhang, T. (2012). Cognitive impairment in rats induced by nano-CuO and its possible mechanisms. Toxicol. Lett. 213, 220-227. doi: 10.1016/j.toxlet.2012.07.007
5. Ascherio, A., Chen, H., Weisskopf, M. G., O'Reilly, E., McCullough, M. L., Calle, E. E., et al. (2006). Pesticide exposure and risk for Parkinson's disease. Ann. Neurol. 60, 197-203. doi: 10.1002/ana.20904
6. Ashok, A., Rai, N. K., Tripathi, S., and Bandyopadhyay, S. (2015). Exposure to As-, Cd- and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats. Toxicol. Sci. 143, 64-80. doi: 10.1093/toxsci/kfu208
7. Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M., Romano, D. M., et al. (1998). Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273, 12817-12826. doi: 10.1074/jbc.273.21.12817
8. Baldi, I., Lebailly, P., Mohammed-Brahim, B., Letenneur, L., Dartigues, J. F., and Brochard, P. (2003). Neurodegenerative diseases and exposure to pesticides in the elderly. Am. J. Epidemiol. 157, 409-414. doi: 10.1093/aje/kwf216
9. Barlow, B. K., Richfield, E. K., Cory-Slechta, D. A., and Thiruchelvam, M. (2004). A fetal risk factor for Parkinson's disease. Dev. Neurosci. 26, 11-23. doi: 10.1159/000080707
10. Basha, M. R., Wei, W., Bakheet, S. A., Benitez, N., Siddiqi, H. K., Ge, Y. W., et al. (2005). The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J. Neurosci. 25, 823-829. doi: 10.1523/jneurosci.4335-04.2005
11. Basun, H., Forssell, L. G., Wetterberg, L., and Winblad, B. (1991). Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J. Neural Transm. Park. Dis. Dement. Sect. 3, 231-258.
12. Baum, L., Chan, I. H., Cheung, S. K., Goggins, W. B., Mok, V., Lam, L., et al. (2010). Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability. Biometals 23, 173-179. doi: 10.1007/s10534-009-9277-5
13. Behl, M., Zhang, Y., Monnot, A. D., Jiang, W., and Zheng, W. (2009). Increased β-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1. Toxicol. Appl. Pharmacol. 240, 245-254. doi: 10.1016/j.taap.2009.05.024
14. Behl, M., Zhang, Y., Shi, Y., Cheng, J., Du, Y., and Zheng, W. (2010). Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C. Neurotoxicology 31, 524-532. doi: 10.1016/j.neuro.2010.05.004
15. Bergen, W. G. (1971). The in vitro effect of dieldrin on respiration of rat liver mitochondria. Proc. Soc. Exp. Biol. Med. 136, 732-735. doi: 10.3181/00379727-136-35352
16. Berry, C., La Vecchia, C., and Nicotera, P. (2010). Paraquat and Parkinson's disease. Cell Death Differ. 17, 1115-1125. doi: 10.1038/cdd.2009.217
17. Betarbet, R., Canet-Aviles, R. M., Sherer, T. B., Mastroberardino, P. G., McLendon, C., Kim, J. H., et al. (2006). Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein and the ubiquitin-proteasome system. Neurobiol. Dis. 22, 404-420. doi: 10.1016/j.nbd.2005.12.003
18. Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. (2000). Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306. doi: 10.1038/81834
19. Bhatt, M. H., Elias, M. A., and Mankodi, A. K. (1999). Acute and reversible parkinsonism due to organophosphate pesticide intoxication: five cases. Neurology 52, 1467-1471. doi: 10.1212/wnl.52.7.1467
20. Bhattacharjee, S., Zhao, Y., Hill, J. M., Percy, M. E., and Lukiw, W. J. (2014). Aluminum and its potential contribution to Alzheimer's disease (AD). Front. Aging Neurosci. 6:62. doi: 10.3389/fnagi.2014.00062
21. Bihaqi, S. W., and Zawia, N. H. (2012). Alzheimer's disease biomarkers and epigenetic intermediates following exposure to Pb in vitro. Curr. Alzheimer Res. 9, 555-562. doi: 10.2174/156720512800617964
22. Bihaqi, S. W., and Zawia, N. H. (2013). Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb). Neurotoxicology 39, 95-101. doi: 10.1016/j.neuro.2013.07.010
23. Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21. doi: 10.1101/gad.947102
24. Botta-Orfila, T., Morató, X., Compta, Y., Lozano, J. J., Falgàs, N., Valldeoriola, F., et al. (2014). Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease. J. Neurosci. Res. 92, 1071-1077. doi: 10.1002/jnr.23377
25. Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory-Slechta, D. A., and Federoff, H. J. (1999). Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. 823, 1-10. doi: 10.1016/s0006-8993(98)01192-5
26. Brown, T. P., Rumsby, P. C., Capleton, A. C., Rushton, L., and Levy, L. S. (2006). Pesticides and Parkinson's disease-is there a link? Environ. Health Perspect. 114, 156-164. doi: 10.1289/ehp.8095
27. Butterfield, D. A., Drake, J., Pocernich, C., and Castegna, A. (2001). Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide. Trends Mol. Med. 7, 548-554. doi: 10.1016/s1471-4914(01)02173-6
28. Buzea, C., Pacheco, I. I., and Robbie, K. (2007). Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2, MR17-MR71. doi: 10.1116/1.2815690
29. Cannon, J. R., Tapias, V., Na, H. M., Honick, A. S., Drolet, R. E., and Greenamyre, J. T. (2009). A highly reproducible rotenone model of Parkinson's disease. Neurobiol. Dis. 34, 279-290. doi: 10.1016/j.nbd.2009.01.016
30. Castello, P. R., Drechsel, D. A., and Patel, M. (2007). Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain. J. Biol. Chem. 282, 14186-14193. doi: 10.1074/jbc.m700827200
31. Chang, J. W., Pai, M. C., Chen, H. L., Guo, H. R., Su, H. J., and Lee, C. C. (2008). Cognitive function and blood methylmercury in adults living near a deserted chloralkali factory. Environ. Res. 108, 334-339. doi: 10.1016/j.envres.2008.06.006
32. Chen, N. N., Luo, D. J., Yao, X. Q., Yu, C., Wang, Y., Wang, Q., et al. (2012b). Pesticides induce spatial memory deficits with synaptic impairments and an imbalanced tau phosphorylation in rats. J. Alzheimers Dis. 30, 585-594. doi: 10.3233/JAD-2012-111946
33. 2. Neurobiol. Aging 33, 432.e15-432.e26. doi: 10.1016/j.neurobiolaging.2011.01.008
34. Chiba-Falek, O., Lopez, G. J., and Nussbaum, R. L. (2006). Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov. Disord. 21, 1703-1708. doi: 10.1002/mds.21007
35. Chin-Chan, M., Segovia, J., Quintanar, L., Arcos-López, T., Hersh, L., Chow, K., et al. (2015). Mercury reduces the enzymatic activity of neprilysin in differentiated SH-SY5Y cells. Toxicol. Sci. doi: 10.1093/toxsci/kfv037. [Epub ahead of print].
36. Clayton, R., Clark, J. B., and Sharpe, M. (2005). Cytochrome c release from rat brain mitochondria is proportional to the mitochondrial functional deficit: implications for apoptosis and neurodegenerative disease. J. Neurochem. 92, 840-849. doi: 10.1111/j.1471-4159.2004.02918.x
37. Cook, D. G., Fahn, S., and Brait, K. A. (1974). Chronic manganese intoxication. Arch. Neurol. 30, 59-64. doi: 10.1001/archneur.1974.00490310061010
38. Cookson, M. R. (2012). Parkinsonism due to mutations in PINK1, parkin and DJ-1 and oxidative stress and mitochondrial pathways. Cold Spring Harb. Perspect. Med. 2:a009415. doi: 10.1101/cshperspect.a009415
39. Coon, S., Stark, A., Peterson, E., Gloi, A., Kortsha, G., Pounds, J., et al. (2006). Whole-body lifetime occupational lead exposure and risk of Parkinson's disease. Environ. Health Perspect. 114, 1872-1876. doi: 10.1289/ehp.9102
40. Corrigan, F. M., Murray, L., Wyatt, C. L., and Shore, R. F. (1998). Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease. Exp. Neurol. 150, 339-342. doi: 10.1006/exnr.1998.6776
41. Corrigan, F. M., Wienburg, C. L., Shore, R. F., Daniel, S. E., and Mann, D. (2000). Organochlorine insecticides in substantia nigra in Parkinson's disease. J. Toxicol. Environ. Health A 59, 229-234. doi: 10.1080/009841000156907
42. Corti, O., Lesage, S., and Brice, A. (2011). What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol. Rev. 91, 1161-1218. doi: 10.1152/physrev.00022.2010
43. Couper, J. (1837). On the effects of black oxide of manganese when inhaled into the lungs. Br. Ann. Med. Pharmacol. 1, 41-42.
44. Cras, P., Kawai, M., Siedlak, S., Mulvihill, P., Gambetti, P., Lowery, D., et al. (1990). Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Am. J. Pathol. 137, 241-246.
45. Dani, S. U. (2010). Arsenic for the fool: an exponential connection. Sci. Total Environ. 408, 1842-1846. doi: 10.1016/j.scitotenv.2010.01.027
46. Desplats, P., Spencer, B., Coffee, E., Patel, P., Michael, S., Patrick, C., et al. (2011). Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J. Biol. Chem. 286, 9031-9037. doi: 10.1074/jbc.C110.212589
47. Dexter, D. T., Carayon, A., Javoy-Agid, F., Agid, Y., Wells, F. R., Daniel, S. E., et al. (1991). Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt. 4), 1953-1975. doi: 10.1093/brain/114.4.1953
48. Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., et al. (1987). Increased nigral iron content in postmortem parkinsonian brain. Lancet 2, 1219-1220. doi: 10.1016/s0140-6736(87)91361-4
49. Dhillon, A. S., Tarbutton, G. L., Levin, J. L., Plotkin, G. M., Lowry, L. K., Nalbone, J. T., et al. (2008). Pesticide/environmental exposures and Parkinson's disease in east texas. J. Agromedicine 13, 37-48. doi: 10.1080/10599240801986215
50. Ding, Q., and Keller, J. N. (2001). Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. J. Neurochem. 77, 1010-1017. doi: 10.1046/j.1471-4159.2001.00302.x
51. Dorsey, C. D., Lee, B. K., Bolla, K. I., Weaver, V. M., Lee, S. S., Lee, G. S., et al. (2006). Comparison of patella lead with blood lead and tibia lead and their associations with neurobehavioral test scores. J. Occup. Environ. Med. 48, 489-496. doi: 10.1097/01.jom.0000199678.86629.3b
52. Drechsel, D. A., and Patel, M. (2009). Differential contribution of the mitochondrial respiratory chain complexes to reactive oxygen species production by redox cycling agents implicated in parkinsonism. Toxicol. Sci. 112, 427-434. doi: 10.1093/toxsci/kfp223
53. Duan, W., Ladenheim, B., Cutler, R. G., Kruman, I. I., Cadet, J. L., and Mattson, M. P. (2002). Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J. Neurochem. 80, 101-110. doi: 10.1046/j.0022-3042.2001.00676.x
54. Etminan, M., Gill, S., and Samii, A. (2003). Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ 327:128. doi: 10.1136/bmj.327.7407.128
55. Exley, C., and Esiri, M. M. (2006). Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK. J. Neurol. Neurosurg. Psychiatry 77, 877-879. doi: 10.1136/jnnp.2005.086553
56. Exley, C., Price, N. C., Kelly, S. M., and Birchall, J. D. (1993). An interaction of beta-amyloid with aluminium in vitro. FEBS Lett. 324, 293-295. doi: 10.1016/0014-5793(93)80137-j
57. Fei, Q., McCormack, A. L., Di Monte, D. A., and Ethell, D. W. (2008). Paraquat neurotoxicity is mediated by a Bak-dependent mechanism. J. Biol. Chem. 283, 3357-3364. doi: 10.1074/jbc.m708451200
58. Firestone, J. A., Smith-Weller, T., Franklin, G., Swanson, P., Longstreth, W. T. Jr., and Checkoway, H. (2005). Pesticides and risk of Parkinson disease: a population-based case-control study. Arch. Neurol. 62, 91-95. doi: 10.1001/archneur.62.1.91
59. Fleming, L., Mann, J. B., Bean, J., Briggle, T., and Sanchez-Ramos, J. R. (1994). Parkinson's disease and brain levels of organochlorine pesticides. Ann. Neurol. 36, 100-103. doi: 10.1002/ana.410360119
60. Franco, R., Li, S., Rodriguez-Rocha, H., Burns, M., and Panayiotidis, M. I. (2010). Molecular mechanisms of pesticide-induced neurotoxicity: relevance to Parkinson's disease. Chem. Biol. Interact. 188, 289-300. doi: 10.1016/j.cbi.2010.06.003
61. Freire, C., and Koifman, S. (2012). Pesticide exposure and Parkinson's disease: epidemiological evidence of association. Neurotoxicology 33, 947-971. doi: 10.1016/j.neuro.2012.05.011
62. Friedhoff, P., von Bergen, M., Mandelkow, E. M., and Mandelkow, E. (2000). Structure of tau protein and assembly into paired helical filaments. Biochim. Biophys. Acta 1502, 122-132. doi: 10.1016/S0925-4439(00)00038-7
63. Fujimura, M., Usuki, F., Sawada, M., and Takashima, A. (2009). Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain. Neurotoxicology 30, 1000-1007. doi: 10.1016/j.neuro.2009.08.001
64. Gao, H. M., and Hong, J. S. (2011). Gene-environment interactions: key to unraveling the mystery of Parkinson's disease. Prog. Neurobiol. 94, 1-19. doi: 10.1016/j.pneurobio.2011.03.005
65. Gao, H. M., Hong, J. S., Zhang, W., and Liu, B. (2002). Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 22, 782-790.
66. Gash, D. M., Rutland, K., Hudson, N. L., Sullivan, P. G., Bing, G., Cass, W. A., et al. (2008). Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Ann. Neurol. 63, 184-192. doi: 10.1002/ana.21288
67. Gatto, N. M., Cockburn, M., Bronstein, J., Manthripragada, A. D., and Ritz, B. (2009). Well-water consumption and Parkinson's disease in rural California. Environ. Health Perspect. 117, 1912-1918. doi: 10.1289/ehp.0900852
68. Gerhardsson, L., Lundh, T., Minthon, L., and Londos, E. (2008). Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 25, 508-515. doi: 10.1159/000129365
69. Gibb, W. R., and Lees, A. J. (1988). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 51, 745-752. doi: 10.1136/jnnp.51.6.745
70. Godfrey, M. E., Wojcik, D. P., and Krone, C. A. (2003). Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity. J. Alzheimers Dis. 5, 189-195.
71. Goedert, M., and Spillantini, M. G. (2006). A century of Alzheimer's disease. Science 314, 777-781. doi: 10.1126/science.1132814
72. Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., and Klug, A. (1988). Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. U S A 85, 4051-4055. doi: 10.1073/pnas.85.11.4051
73. Goldman, S. M. (2014). Environmental toxins and Parkinson's disease. Annu. Rev. Pharmacol. Toxicol. 54, 141-164. doi: 10.1146/annurev-pharmtox-011613-135937
74. Goldman, S. M., Quinlan, P. J., Ross, G. W., Marras, C., Meng, C., Bhudhikanok, G. S., et al. (2012). Solvent exposures and Parkinson disease risk in twins. Ann. Neurol. 71, 776-784. doi: 10.1002/ana.22629
75. Gong, G., and O'Bryant, S. E. (2010). The arsenic exposure hypothesis for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 24, 311-316. doi: 10.1097/WAD.0b013e3181d71bc7
76. González-Polo, R. A., Rodríguez-Martín, A., Morán, J. M., Niso, M., Soler, G., and Fuentes, J. M. (2004). Paraquat-induced apoptotic cell death in cerebellar granule cells. Brain Res. 1011, 170-176. doi: 10.1016/s0006-8993(04)00466-4
77. Goodall, E. F., Heath, P. R., Bandmann, O., Kirby, J., and Shaw, P. J. (2013). Neuronal dark matter: the emerging role of microRNAs in neurodegeneration. Front. Cell. Neurosci. 7:178. doi: 10.3389/fncel.2013.00178
78. Gorell, J. M., Peterson, E. L., Rybicki, B. A., and Johnson, C. C. (2004). Multiple risk factors for Parkinson's disease. J. Neurol. Sci. 217, 169-174. doi: 10.1016/j.jns.2003.09.014
79. Götz, J. (2001). Tau and transgenic animal models. Brain Res. Brain Res. Rev. 35, 266-286. doi: 10.1016/s0165-0173(01)00055-8
80. Greenblatt, J. M., Huffman, L. C., and Reiss, A. L. (1994). Folic acid in neurodevelopment and child psychiatry. Prog. Neuropsychopharmacol. Biol. Psychiatry 18, 647-660. doi: 10.1016/0278-5846(94)90074-4
81. Gu, H., Wei, X., Monnot, A. D., Fontanilla, C. V., Behl, M., Farlow, M. R., et al. (2011). Lead exposure increases levels of beta-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice. Neurosci. Lett. 490, 16-20. doi: 10.1016/j.neulet.2010.12.017
82. Guilarte, T. R. (2013). Manganese neurotoxicity: new perspectives from behavioral, neuroimaging and neuropathological studies in humans and non-human primates. Front. Aging Neurosci. 5:23. doi: 10.3389/fnagi.2013.00023
83. Halliwell, B., Gutteridge, J. M., and Cross, C. E. (1992). Free radicals, antioxidants and human disease: where are we now? J. Lab. Clin. Med. 119, 598-620.
84. Hardy, J. A., and Higgins, G. A. (1992). Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185. doi: 10.1126/science.1566067
85. Harischandra, D. S., Jin, H., Anantharam, V., Kanthasamy, A., and Kanthasamy, A. G. (2015). α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease. Toxicol. Sci. 143, 454-468. doi: 10.1093/toxsci/kfu247
86. Hatcher, J. M., Pennell, K. D., and Miller, G. W. (2008). Parkinson's disease and pesticides: a toxicological perspective. Trends Pharmacol. Sci. 29, 322-329. doi: 10.1016/j.tips.2008.03.007
87. Hatcher, J. M., Richardson, J. R., Guillot, T. S., McCormack, A. L., Di Monte, D. A., Jones, D. P., et al. (2007). Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp. Neurol. 204, 619-630. doi: 10.1016/j.expneurol.2006.12.020
88. Hayden, K. M., Norton, M. C., Darcey, D., Ostbye, T., Zandi, P. P., Breitner, J. C., et al. (2010). Occupational exposure to pesticides increases the risk of incident AD: the Cache County study. Neurology 74, 1524-1530. doi: 10.1212/WNL.0b013e3181dd4423
89. Hernandez, M. E., Rembao, J. D., Hernandez-Baltazar, D., Castillo-Rodriguez, R. A., Tellez-Lopez, V. M., Flores-Martinez, Y. M., et al. (2014). Safety of the intravenous administration of neurotensin-polyplex nanoparticles in BALB/c mice. Nanomedicine 10, 745-754. doi: 10.1016/j.nano.2013.11.013
90. Hertzman, C., Wiens, M., Bowering, D., Snow, B., and Calne, D. (1990). Parkinson's disease: a case-control study of occupational and environmental risk factors. Am. J. Ind. Med. 17, 349-355. doi: 10.1002/ajim.4700170307
91. Hirsch, E. C., Brandel, J. P., Galle, P., Javoy-Agid, F., and Agid, Y. (1991). Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J. Neurochem. 56, 446-451. doi: 10.1111/j.1471-4159.1991.tb08170.x
92. Hock, C., Drasch, G., Golombowski, S., Müller-Spahn, F., Willershausen-Zonnchen, B., Schwarz, P., et al. (1998). Increased blood mercury levels in patients with Alzheimer's disease. J. Neural Transm. 105, 59-68. doi: 10.1007/s007020050038
93. Holliday, R. (2006). Epigenetics: a historical overview. Epigenetics 1, 76-80. doi: 10.4161/epi.1.2.2762
94. Huang, H., Bihaqi, S. W., Cui, L., and Zawia, N. H. (2011). In vitro Pb exposure disturbs the balance between Aβ production and elimination: the role of AbetaPP and neprilysin. Neurotoxicology 32, 300-306. doi: 10.1016/j.neuro.2011.02.001
95. Huang, C. L., Hsiao, I. L., Lin, H. C., Wang, C. F., Huang, Y. J., and Chuang, C. Y. (2015). Silver nanoparticles affect on gene expression of inflammatory and neurodegenerative responses in mouse brain neural cells. Environ. Res. 136, 253-263. doi: 10.1016/j.envres.2014.11.006
96. Huang, C. C., Lu, C. S., Chu, N. S., Hochberg, F., Lilienfeld, D., Olanow, W., et al. (1993). Progression after chronic manganese exposure. Neurology 43, 1479-1483. doi: 10.1212/WNL.43.8.1479
97. Iwata, A., Nagata, K., Hatsuta, H., Takuma, H., Bundo, M., Iwamoto, K., et al. (2014). Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation. Hum. Mol. Genet. 23, 648-656. doi: 10.1093/hmg/ddt451
98. Jang, H., and Serra, C. (2014). Nutrition, epigenetics and diseases. Clin. Nutr. Res. 3, 1-8. doi: 10.7762/cnr.2014.3.1.1
99. Jankovic, J. (2005). Searching for a relationship between manganese and welding and Parkinson's disease. Neurology 64, 2021-2028. doi: 10.1212/01.wnl.0000166916.40902.63
100. Jankovic, J. (2008). Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79, 368-376. doi: 10.1136/jnnp.2007.131045
101. Jiang, L. F., Yao, T. M., Zhu, Z. L., Wang, C., and Ji, L. N. (2007). Impacts of Cd(II) on the conformation and self-aggregation of Alzheimer's tau fragment corresponding to the third repeat of microtubule-binding domain. Biochim. Biophys. Acta 1774, 1414-1421. doi: 10.1016/j.bbapap.2007.08.014
102. Johansson, C., Castoldi, A. F., Onishchenko, N., Manzo, L., Vahter, M., and Ceccatelli, S. (2007). Neurobehavioural and molecular changes induced by methylmercury exposure during development. Neurotox. Res. 11, 241-260. doi: 10.1007/bf03033570
103. Jowaed, A., Schmitt, I., Kaut, O., and Wüllner, U. (2010). Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. J. Neurosci. 30, 6355-6359. doi: 10.1523/jneurosci.6119-09.2010
104. Kala, S. V., and Jadhav, A. L. (1995). Low level lead exposure decreases in vivo release of dopamine in the rat nucleus accumbens: a microdialysis study. J. Neurochem. 65, 1631-1635. doi: 10.1046/j.1471-4159.1995.65041631.x
105. Kamel, F., Tanner, C., Umbach, D., Hoppin, J., Alavanja, M., Blair, A., et al. (2007). Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am. J. Epidemiol. 165, 364-374. doi: 10.1093/aje/kwk024
106. Kang, M. J., Gil, S. J., and Koh, H. C. (2009). Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice. Toxicol. Lett. 188, 148-152. doi: 10.1016/j.toxlet.2009.03.026
107. Kanthasamy, A. G., Kitazawa, M., Kanthasamy, A., and Anantharam, V. (2005). Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis. Neurotoxicology 26, 701-719. doi: 10.1016/j.neuro.2004.07.010
108. Kaur, D., Peng, J., Chinta, S. J., Rajagopalan, S., Di Monte, D. A., Cherny, R. A., et al. (2007). Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol. Aging 28, 907-913. doi: 10.1016/j.neurobiolaging.2006.04.003
109. Kawahara, M., Kato, M., and Kuroda, Y. (2001). Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res. Bull. 55, 211-217. doi: 10.1016/s0361-9230(01)00475-0
110. Kim, D. K., Park, J. D., and Choi, B. S. (2014). Mercury-induced amyloid-beta (Aβ) accumulation in the brain is mediated by disruption of Aβ transport. J. Toxicol. Sci. 39, 625-635. doi: 10.2131/jts.39.625
111. Kitazawa, M., Anantharam, V., and Kanthasamy, A. G. (2001). Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells. Free Radic. Biol. Med. 31, 1473-1485. doi: 10.1016/s0891-5849(01)00726-2
112. Kitazawa, M., Anantharam, V., and Kanthasamy, A. G. (2003). Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration. Neuroscience 119, 945-964. doi: 10.1016/s0306-4522(03)00226-4
113. Kochen, W., Kohlmüller, D., De Biasi, P., and Ramsay, R. (2003). The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson's disease. Adv. Exp. Med. Biol. 527, 253-263. doi: 10.1007/978-1-4615-0135-0_29
114. Kojro, E., and Fahrenholz, F. (2005). The non-amyloidogenic pathway: structure and function of alpha-secretases. Subcell Biochem. 38, 105-127. doi: 10.1007/0-387-23226-5_5
115. Kuhn, W., Winkel, R., Woitalla, D., Meves, S., Przuntek, H., and Müller, T. (1998). High prevalence of parkinsonism after occupational exposure to lead-sulfate batteries. Neurology 50, 1885-1886. doi: 10.1212/wnl.50.6.1885
116. Kuter, K., Nowak, P., Golembiowska, K., and Ossowska, K. (2010). Increased reactive oxygen species production in the brain after repeated low-dose pesticide paraquat exposure in rats. A comparison with peripheral tissues. Neurochem. Res. 35, 1121-1130. doi: 10.1007/s11064-010-0163-x
117. Kwok, J. B. (2010). Role of epigenetics in Alzheimer's and Parkinson's disease. Epigenomics 2, 671-682. doi: 10.2217/epi.10.43
118. Lai, B. C., Marion, S. A., Teschke, K., and Tsui, J. K. (2002). Occupational and environmental risk factors for Parkinson's disease. Parkinsonism Relat. Disord. 8, 297-309. doi: 10.1016/s1353-8020(01)00054-2
119. Langston, J. W., and Ballard, P. A. Jr. (1983). Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N. Engl. J. Med. 309, 310. doi: 10.1056/nejm198308043090511
120. Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, I. (1983). Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980. doi: 10.1126/science.6823561
121. Langston, J. W., Forno, L. S., Rebert, C. S., and Irwin, I. (1984). Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res. 292, 390-394. doi: 10.1016/0006-8993(84)90777-7
122. Lee, J. W. (2000). Manganese intoxication. Arch. Neurol. 57, 597-599. doi: 10.1001/archneur.57.4.597
123. Lewczuk, P., Mroczko, B., Fagan, A., and Kornhuber, J. (2014). Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective. Adv. Med. Sci. 60, 76-82. doi: 10.1016/j.advms.2014.11.002
124. Leyva-Gómez, G., Cortés, H., Magaña, J. J., Leyva-García, N., Quintanar-Guerrero, D., and Florán, B. (2015). Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain. Drug Discov. Today. doi: 10.1016/j.drudis.2015.02.009. [Epub ahead of print].
125. Li, W. J., Jiang, H., Song, N., and Xie, J. X. (2010b). Dose- and time-dependent alpha-synuclein aggregation induced by ferric iron in SK-N-SH cells. Neurosci. Bull. 26, 205-210. doi: 10.1007/s12264-010-1117-7
126. Li, G., Kim, C., Kim, J., Yoon, H., Zhou, H., and Kim, J. (2015). Common pesticide, dichlorodiphenyltrichloroethane (DDT), increases amyloid-beta levels by impairing the function of ABCA1 and IDE: implication for Alzheimer's disease. J. Alzheimers Dis. doi: 10.3233/JAD-150024. [Epub ahead of print].
127. Li, X., Liu, B., Li, X. L., Li, Y. X., Sun, M. Z., Chen, D. Y., et al. (2014b). SiO2 nanoparticles change colour preference and cause Parkinson's-like behaviour in zebrafish. Sci. Rep. 4:3810. doi: 10.1038/srep03810
128. Li, N., Liu, F., Song, L., Zhang, P., Qiao, M., Zhao, Q., et al. (2014a). The effects of early life Pb exposure on the expression of IL1-beta, TNF-alpha and Abeta in cerebral cortex of mouse pups. J. Trace Elem. Med. Biol. 28, 100-104. doi: 10.1016/j.jtemb.2013.07.003
129. Li, X., Lv, Y., Yu, S., Zhao, H., and Yao, L. (2012). The effect of cadmium on Abeta levels in APP/PS1 transgenic mice. Exp. Ther. Med. 4, 125-130. doi: 10.3892/etm.2012.562
130. Li, N., Yu, Z. L., Wang, L., Zheng, Y. T., Jia, J. X., Wang, Q., et al. (2010a). Increased tau phosphorylation and beta amyloid in the hipocampus of mouse pups by early life lead exposure. Acta Biol. Hung. 61, 123-134. doi: 10.1556/abiol.61.2010.2.1
131. Liou, H. H., Tsai, M. C., Chen, C. J., Jeng, J. S., Chang, Y. C., Chen, S. Y., et al. (1997). Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 48, 1583-1588. doi: 10.1212/wnl.48.6.1583
132. Liu, M., Choi, D. Y., Hunter, R. L., Pandya, J. D., Cass, W. A., Sullivan, P. G., et al. (2010). Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. J. Neurochem. 112, 773-783. doi: 10.1111/j.1471-4159.2009.06497.x
133. Liu, P., Huang, Z., and Gu, N. (2013). Exposure to silver nanoparticles does not affect cognitive outcome or hippocampal neurogenesis in adult mice. Ecotoxicol. Environ. Saf. 87, 124-130. doi: 10.1016/j.ecoenv.2012.10.014
134. Liu, F., Xue, Z., Li, N., Huang, H., Ying, Y., Li, J., et al. (2014). Effects of lead exposure on the expression of amyloid beta and phosphorylated tau proteins in the C57BL/6 mouse hippocampus at different life stages. J. Trace Elem. Med. Biol. 28, 227-232. doi: 10.1016/j.jtemb.2014.01.002
135. Lock, E. A., Zhang, J., and Checkoway, H. (2013). Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence. Toxicol. Appl. Pharmacol. 266, 345-355. doi: 10.1016/j.taap.2012.11.016
136. Logroscino, G. (2005). The role of early life environmental risk factors in Parkinson disease: what is the evidence?Environ. Health Perspect. 113, 1234-1238. doi: 10.1289/ehp.7573
137. Logroscino, G., Gao, X., Chen, H., Wing, A., and Ascherio, A. (2008). Dietary iron intake and risk of Parkinson's disease. Am. J. Epidemiol. 168, 1381-1388. doi: 10.1093/aje/kwn273
138. Lu, C. S., Huang, C. C., Chu, N. S., and Calne, D. B. (1994). Levodopa failure in chronic manganism. Neurology 44, 1600-1602. doi: 10.1212/wnl.44.9.1600
139. Lu, H., Liu, X., Deng, Y., and Qing, H. (2013). DNA methylation, a hand behind neurodegenerative diseases. Front. Aging Neurosci. 5:85. doi: 10.3389/fnagi.2013.00085
140. Lui, E., Fisman, M., Wong, C., and Diaz, F. (1990). Metals and the liver in Alzheimer's disease. An investigation of hepatic zinc, copper, cadmium and metallothionein. J. Am. Geriatr. Soc. 38, 633-639.
141. Lukiw, W. J. (2012). NF-kappaB-regulated, proinflammatory miRNAs in Alzheimer's disease. Alzheimers Res. Ther. 4:47. doi: 10.1186/alzrt150
142. Luo, Y., Niu, F., Sun, Z., Cao, W., Zhang, X., Guan, D., et al. (2009). Altered expression of Abeta metabolism-associated molecules from D-galactose/AlCl(3) induced mouse brain. Mech. Ageing Dev. 130, 248-252. doi: 10.1016/j.mad.2008.12.005
143. Maciotta, S., Meregalli, M., and Torrente, Y. (2013). The involvement of microRNAs in neurodegenerative diseases. Front. Cell. Neurosci. 7:265. doi: 10.3389/fncel.2013.00265
144. Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., and Di Monte, D. A. (2002). The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J. Biol. Chem. 277, 1641-1644. doi: 10.1074/jbc.c100560200
145. Mao, H., and Liu, B. (2008). Synergistic microglial reactive oxygen species generation induced by pesticides lindane and dieldrin. Neuroreport 19, 1317-1320. doi: 10.1097/wnr.0b013e32830b3677
146. Marques, S. C., Oliveira, C. R., Pereira, C. M., and Outeiro, T. F. (2011). Epigenetics in neurodegeneration: a new layer of complexity. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 348-355. doi: 10.1016/j.pnpbp.2010.08.008
147. Martínez, L., Jiménez, V., García-Sepúlveda, C., Ceballos, F., Delgado, J. M., Niño-Moreno, P., et al. (2011). Impact of early developmental arsenic exposure on promotor CpG-island methylation of genes involved in neuronal plasticity. Neurochem. Int. 58, 574-581. doi: 10.1016/j.neuint.2011.01.020
148. Mason, L. H., Harp, J. P., and Han, D. Y. (2014). Pb neurotoxicity: neuropsychological effects of lead toxicity. Biomed. Res. Int. 2014:840547. doi: 10.1155/2014/840547
149. Matsumoto, L., Takuma, H., Tamaoka, A., Kurisaki, H., Date, H., Tsuji, S., et al. (2010). CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease. PLoS One 5:e15522. doi: 10.1371/journal.pone.0015522
150. McCormack, A. L., Atienza, J. G., Johnston, L. C., Andersen, J. K., Vu, S., and Di Monte, D. A. (2005). Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J. Neurochem. 93, 1030-1037. doi: 10.1111/j.1471-4159.2005.03088.x
151. McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A., et al. (2002). Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis. 10, 119-127. doi: 10.1006/nbdi.2002.0507
152. McDonnell, L., Maginnis, C., Lewis, S., Pickering, N., Antoniak, M., Hubbard, R., et al. (2003). Occupational exposure to solvents and metals and Parkinson's disease. Neurology 61, 716-717. doi: 10.1212/wnl.61.5.716
153. McNaught, K. S., Belizaire, R., Jenner, P., Olanow, C. W., and Isacson, O. (2002). Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci. Lett. 326, 155-158. doi: 10.1016/s0304-3940(02)00296-3
154. McNaught, K. S., and Jenner, P. (2001). Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297, 191-194. doi: 10.1016/s0304-3940(00)01701-8
155. Miñones-Moyano, E., Porta, S., Escaramis, G., Rabionet, R., Iraola, S., Kagerbauer, B., et al. (2011). MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 20, 3067-3078. doi: 10.1093/hmg/ddr210
156. Miyake, Y., Tanaka, K., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., et al. (2011). Dietary intake of metals and risk of Parkinson's disease: a case-control study in Japan. J. Neurol. Sci. 306, 98-102. doi: 10.1016/j.jns.2011.03.035
157. Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., and Nagatsu, T. (1996). Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci. Lett. 211, 13-16. doi: 10.1016/0304-3940(96)12706-3
158. Monnet-Tschudi, F., Zurich, M. G., Boschat, C., Corbaz, A., and Honegger, P. (2006). Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases. Rev. Environ. Health 21, 105-117. doi: 10.1515/reveh.2006.21.2.105
159. Mortimer, J. A., Borenstein, A. R., and Nelson, L. M. (2012). Associations of welding and manganese exposure with Parkinson disease: review and meta-analysis. Neurology 79, 1174-1180. doi: 10.1212/WNL.0b013e3182698ced
160. Mutter, J., Naumann, J., Sadaghiani, C., Schneider, R., and Walach, H. (2004). Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator. Neuro. Endocrinol. Lett. 25, 331-339.
161. Nalivaeva, N. N., Beckett, C., Belyaev, N. D., and Turner, A. J. (2012). Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? J. Neurochem. 120(Suppl. 1), 167-185. doi: 10.1111/j.1471-4159.2011.07510.x
162. Nasuti, C., Carloni, M., Fedeli, D., Gabbianelli, R., Di Stefano, A., Serafina, C. L., et al. (2013). Effects of early life permethrin exposure on spatial working memory and on monoamine levels in different brain areas of pre-senescent rats. Toxicology 303, 162-168. doi: 10.1016/j.tox.2012.09.016
163. Navarro-Yepes, J., Zavala-Flores, L., Anandhan, A., Wang, F., Skotak, M., Chandra, N., et al. (2014). Antioxidant gene therapy against neuronal cell death. Pharmacol. Ther. 142, 206-230. doi: 10.1016/j.pharmthera.2013.12.007
164. O'Bryant, S. E., Edwards, M., Menon, C. V., Gong, G., and Barber, R. (2011). Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a Project FRONTIER study. Int. J. Environ. Res. Public Health 8, 861-874. doi: 10.3390/ijerph8030861
165. Olivieri, G., Brack, C., Müller-Spahn, F., Stähelin, H. B., Herrmann, M., Renard, P., et al. (2000). Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells. J. Neurochem. 74, 231-236. doi: 10.1046/j.1471-4159.2000.0740231.x
166. Papageorgiou, S. G., Karantoni, E., Pandis, D., Kouzoupis, A. V., Kalfakis, N., and Limouris, G. S. (2009). Severe dopaminergic pathways damage in a case of chronic toluene abuse. Clin. Neurol. Neurosurg. 111, 864-867. doi: 10.1016/j.clineuro.2009.07.007
167. Park, R. M. (2013). Neurobehavioral deficits and parkinsonism in occupations with manganese exposure: a review of methodological issues in the epidemiological literature. Saf. Health Work 4, 123-135. doi: 10.1016/j.shaw.2013.07.003
168. Park, J. H., Lee, D. W., Park, K. S., and Joung, H. (2014). Serum trace metal levels in Alzheimer's disease and normal control groups. Am. J. Alzheimers Dis. Other Demen. 29, 76-83. doi: 10.1177/1533317513506778
169. Peris-Sampedro, F., Salazar, J. G., Cabré, M., Reverte, I., Domingo, J. L., Sánchez-Santed, F., et al. (2014). Impaired retention in AbetaPP Swedish mice six months after oral exposure to chlorpyrifos. Food Chem. Toxicol. 72, 289-294. doi: 10.1016/j.fct.2014.07.036
170. Perl, D. P., and Olanow, C. W. (2007). The neuropathology of manganese-induced Parkinsonism. J. Neuropathol. Exp. Neurol. 66, 675-682. doi: 10.1097/nen.0b013e31812503cf
171. Pezzoli, G., Barbieri, S., Ferrante, C., Zecchinelli, A., and Foà, V. (1989). Parkinsonism due to n-hexane exposure. Lancet 2:874. doi: 10.1016/s0140-6736(89)93050-x
172. Pezzoli, G., Ricciardi, S., Masotto, C., Mariani, C. B., and Carenzi, A. (1990). n-hexane induces parkinsonism in rodents. Brain Res. 531, 355-357. doi: 10.1016/0006-8993(90)90801-h
173. Piaceri, I., Nacmias, B., and Sorbi, S. (2013). Genetics of familial and sporadic Alzheimer's disease. Front. Biosci. (Elite Ed.) 5, 167-177. doi: 10.2741/e605
174. Pieper, H. C., Evert, B. O., Kaut, O., Riederer, P. F., Waha, A., and Wullner, U. (2008). Different methylation of the TNF-alpha promoter in cortex and substantia nigra: implications for selective neuronal vulnerability. Neurobiol. Dis. 32, 521-527. doi: 10.1016/j.nbd.2008.09.010
175. Pisanic, T. R. 2nd, Blackwell, J. D., Shubayev, V. I., Fiñones, R. R., and Jin, S. (2007). Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 28, 2572-2581. doi: 10.1016/j.biomaterials.2007.01.043
176. Pogue, A. I., Percy, M. E., Cui, J. G., Li, Y. Y., Bhattacharjee, S., Hill, J. M., et al. (2011). Up-regulation of NF-kB-sensitive miRNA-125b and miRNA-146a in metal sulfate-stressed human astroglial (HAG) primary cell cultures. J. Inorg. Biochem. 105, 1434-1437. doi: 10.1016/j.jinorgbio.2011.05.012
177. Poirier, L. A., and Vlasova, T. I. (2002). The prospective role of abnormal methyl metabolism in cadmium toxicity. Environ. Health Perspect. 110(Suppl. 5), 793-795. doi: 10.1289/ehp.02110s5793
178. Praticò, D., Uryu, K., Sung, S., Tang, S., Trojanowski, J. Q., and Lee, V. M. (2002). Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J. 16, 1138-1140. doi: 10.1096/fj.02-0012fje
179. Priyadarshi, A., Khuder, S. A., Schaub, E. A., and Priyadarshi, S. S. (2001). Environmental risk factors and Parkinson's disease: a metaanalysis. Environ. Res. 86, 122-127. doi: 10.1006/enrs.2001.4264
180. Priyadarshi, A., Khuder, S. A., Schaub, E. A., and Shrivastava, S. (2000). A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology 21, 435-440.
181. Purisai, M. G., McCormack, A. L., Cumine, S., Li, J., Isla, M. Z., and Di Monte, D. A. (2007). Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration. Neurobiol. Dis. 25, 392-400. doi: 10.1016/j.nbd.2006.10.008
182. Purkerson-Parker, S., McDaniel, K. L., and Moser, V. C. (2001). Dopamine transporter binding in the rat striatum is increased by gestational, perinatal and adolescent exposure to heptachlor. Toxicol. Sci. 64, 216-223. doi: 10.1093/toxsci/64.2.216
183. Radad, K., Rausch, W. D., and Gille, G. (2006). Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. Neurochem. Int. 49, 379-386. doi: 10.1016/j.neuint.2006.02.003
184. Ramos-Chávez, L. A., Rendón-López, C. R., Zepeda, A., Silva-Adaya, D., Del Razo, L. M., and Gonsebatt, M. E. (2015). Neurological effects of inorganic arsenic exposure: altered cysteine/glutamate transport, NMDA expression and spatial memory impairment. Front. Cell. Neurosci. 9:21. doi: 10.3389/fncel.2015.00021
185. Rappold, P. M., Cui, M., Chesser, A. S., Tibbett, J., Grima, J. C., Duan, L., et al. (2011). Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3. Proc. Natl. Acad. Sci. U S A 108, 20766-20771. doi: 10.1073/pnas.1115141108
186. Ray, P. D., Yosim, A., and Fry, R. C. (2014). Incorporating epigenetic data into the risk assessment process for the toxic metals arsenic, cadmium, chromium, lead and mercury: strategies and challenges. Front. Genet. 5:201. doi: 10.3389/fgene.2014.00201
187. Richardson, J. R., Roy, A., Shalat, S. L., von Stein, R. T., Hossain, M. M., Duan, B., et al. (2014). Elevated serum pesticide levels and risk for Alzheimer disease. JAMA Neurol. 71, 284-290. doi: 10.1001/jamaneurol.2013.6030
188. Rodier, J. (1955). Manganese poisoning in Moroccan miners. Br. J. Ind. Med. 12, 21-35. doi: 10.1136/oem.12.1.21
189. Rogers, J. T., Leiter, L. M., McPhee, J., Cahill, C. M., Zhan, S. S., Potter, H., et al. (1999). Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences. J. Biol. Chem. 274, 6421-6431. doi: 10.1074/jbc.274.10.6421
190. Rogers, J., and Lue, L. F. (2001). Microglial chemotaxis, activation and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 39, 333-340. doi: 10.1016/s0197-0186(01)00040-7
191. Rybicki, B. A., Johnson, C. C., Uman, J., and Gorell, J. M. (1993). Parkinson's disease mortality and the industrial use of heavy metals in Michigan. Mov. Disord. 8, 87-92. doi: 10.1002/mds.870080116
192. Sakamoto, T., Saito, H., Ishii, K., Takahashi, H., Tanabe, S., and Ogasawara, Y. (2006). Aluminum inhibits proteolytic degradation of amyloid beta peptide by cathepsin D: a potential link between aluminum accumulation and neuritic plaque deposition. FEBS Lett. 580, 6543-6549. doi: 10.1016/j.febslet.2006.10.075
193. Salazar, J. G., Ribes, D., Cabré, M., Domingo, J. L., Sanchez-Santed, F., and Colomina, M. T. (2011). Amyloid beta peptide levels increase in brain of AbetaPP Swedish mice after exposure to chlorpyrifos. Curr. Alzheimer Res. 8, 732-740. doi: 10.2174/156720511797633197
194. Sanchez-Ramos, J., Facca, A., Basit, A., and Song, S. (1998). Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures. Exp. Neurol. 150, 263-271. doi: 10.1006/exnr.1997.6770
195. Sandhir, R., Julka, D., and Gill, K. D. (1994). Lipoperoxidative damage on lead exposure in rat brain and its implications on membrane bound enzymes. Pharmacol. Toxicol. 74, 66-71. doi: 10.1111/j.1600-0773.1994.tb01077.x
196. Schmuck, G., Röhrdanz, E., Tran-Thi, Q. H., Kahl, R., and Schlüter, G. (2002). Oxidative stress in rat cortical neurons and astrocytes induced by paraquat in vitro. Neurotox. Res. 4, 1-13. doi: 10.1080/10298420290007574
197. Schrag, A., Ben-Shlomo, Y., and Quinn, N. (2002). How valid is the clinical diagnosis of Parkinson's disease in the community? J. Neurol. Neurosurg. Psychiatry 73, 529-534. doi: 10.1136/jnnp.73.5.529
198. Sharma, H. S., Ali, S. F., Hussain, S. M., Schlager, J. J., and Sharma, A. (2009). Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J. Nanosci. Nanotechnol. 9, 5055-5072. doi: 10.1166/jnn.2009.gr09
199. Sharma, H. S., and Sharma, A. (2012). Neurotoxicity of engineered nanoparticles from metals. CNS Neurol. Disord. Drug Targets 11, 65-80. doi: 10.2174/187152712799960817
200. Shen, X. L., Yu, J. H., Zhang, D. F., Xie, J. X., and Jiang, H. (2014). Positive relationship between mortality from Alzheimer's disease and soil metal concentration in mainland China. J. Alzheimers Dis. 42, 893-900. doi: 10.3233/JAD-140153
201. Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., et al. (2002). An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J. Neurosci. 22, 7006-7015.
202. Sherer, T. B., Kim, J. H., Betarbet, R., and Greenamyre, J. T. (2003). Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp. Neurol. 179, 9-16. doi: 10.1006/exnr.2002.8072
203. Sherer, T. B., Richardson, J. R., Testa, C. M., Seo, B. B., Panov, A. V., Yagi, T., et al. (2007). Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J. Neurochem. 100, 1469-1479. doi: 10.1111/j.1471-4159.2006.04333.x
204. Shin, R. W., Kruck, T. P., Murayama, H., and Kitamoto, T. (2003). A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease. Brain Res. 961, 139-146. doi: 10.1016/s0006-8993(02)03893-3
205. Shin, R. W., Lee, V. M., and Trojanowski, J. Q. (1994). Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro. J. Neurosci. 14, 7221-7233.
206. Sian-Hulsmann, J., Mandel, S., Youdim, M. B., and Riederer, P. (2011). The relevance of iron in the pathogenesis of Parkinson's disease. J. Neurochem. 118, 939-957. doi: 10.1111/j.1471-4159.2010.07132.x
207. Singer, S. M., Chambers, C. B., Newfry, G. A., Norlund, M. A., and Muma, N. A. (1997). Tau in aluminum-induced neurofibrillary tangles. Neurotoxicology 18, 63-76.
208. Smargiassi, A., Mutti, A., De Rosa, A., De Palma, G., Negrotti, A., and Calzetti, S. (1998). A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. Neurotoxicology 19, 709-712.
209. Smith, M. A., Harris, P. L., Sayre, L. M., and Perry, G. (1997a). Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U S A 94, 9866-9868. doi: 10.1073/pnas.94.18.9866
210. Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., and Perry, G. (1997b). Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17, 2653-2657.
211. Song, J. W., and Choi, B. S. (2013). Mercury induced the accumulation of amyloid beta (Abeta) in PC12 cells: the role of production and degradation of abeta. Toxicol. Res. 29, 235-240. doi: 10.5487/tr.2013.29.4.235
212. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., and Goedert, M. (1998). alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U S A 95, 6469-6473. doi: 10.1073/pnas.95.11.6469
213. Stohs, S. J., and Bagchi, D. (1995). Oxidative mechanisms in the toxicity of metal ions. Free Radic. Biol. Med. 18, 321-336. doi: 10.1016/0891-5849(94)00159-h
214. Sun, F., Anantharam, V., Latchoumycandane, C., Kanthasamy, A., and Kanthasamy, A. G. (2005). Dieldrin induces ubiquitin-proteasome dysfunction in alpha-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death. J. Pharmacol. Exp. Ther. 315, 69-79. doi: 10.1124/jpet.105.084632
215. Sun, X., Bromley-Brits, K., and Song, W. (2012). Regulation of beta-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer's disease. J. Neurochem. 120(Suppl. 1), 62-70. doi: 10.1111/j.1471-4159.2011.07515.x
216. Suri, S., Heise, V., Trachtenberg, A. J., and Mackay, C. E. (2013). The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE varepsilon2. Neurosci. Biobehav. Rev. 37, 2878-2886. doi: 10.1016/j.neubiorev.2013.10.010
217. Tanner, C. M., and Goldman, S. M. (1996). Epidemiology of Parkinson's disease. Neurol. Clin. 14, 317-335. doi: 10.1016/S0733-8619(05)70259-0
218. Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., et al. (2011). Rotenone, paraquat and Parkinson's disease. Environ. Health Perspect. 119, 866-872. doi: 10.1289/ehp.1002839
219. Tavakoli-Nezhad, M., and Pitts, D. K. (2005). Postnatal inorganic lead exposure reduces midbrain dopaminergic impulse flow and decreases dopamine D1 receptor sensitivity in nucleus accumbens neurons. J. Pharmacol. Exp. Ther. 312, 1280-1288. doi: 10.1124/jpet.104.076166
220. Thinakaran, G., and Koo, E. H. (2008). Amyloid precursor protein trafficking, processing and function. J. Biol. Chem. 283, 29615-29619. doi: 10.1074/jbc.r800019200
221. Thiruchelvam, M., Richfield, E. K., Goodman, B. M., Baggs, R. B., and Cory-Slechta, D. A. (2002). Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 23, 621-633. doi: 10.1016/s0161-813x(02)00092-x
222. Tokimasa, M., Minoura, K., Hiraoka, S., Tomoo, K., Sumida, M., Taniguchi, T., et al. (2005). Importance of local structures of second and third repeat fragments of microtubule-binding domain for tau filament formation. FEBS Lett. 579, 3481-3486. doi: 10.1016/j.febslet.2005.05.020
223. Tuppo, E. E., and Arias, H. R. (2005). The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell Biol. 37, 289-305. doi: 10.1016/j.biocel.2004.07.009
224. Tyler, C. R., and Allan, A. M. (2014). The effects of arsenic exposure on neurological and cognitive dysfunction in human and rodent studies: a review. Curr. Environ. Health Rep. 1, 132-147. doi: 10.1007/s40572-014-0012-1
225. Uversky, V. N., Li, J., and Fink, A. L. (2001). Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease. FEBS Lett. 500, 105-108. doi: 10.1016/s0014-5793(01)02597-2
226. Vahidnia, A., Romijn, F., Van der Voet, G. B., and de Wolff, F. A. (2008). Arsenic-induced neurotoxicity in relation to toxicokinetics: effects on sciatic nerve proteins. Chem. Biol. Interact. 176, 188-195. doi: 10.1016/j.cbi.2008.07.001
227. Vallelunga, A., Ragusa, M., Di Mauro, S., Iannitti, T., Pilleri, M., Biundo, R., et al. (2014). Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and multiple system atrophy. Front. Cell. Neurosci. 8:156. doi: 10.3389/fncel.2014.00156
228. Van den Hove, D. L., Kompotis, K., Lardenoije, R., Kenis, G., Mill, J., Steinbusch, H. W., et al. (2014). Epigenetically regulated microRNAs in Alzheimer's disease. Neurobiol. Aging 35, 731-745. doi: 10.1016/j.neurobiolaging.2013.10.082
229. van der Mark, M., Brouwer, M., Kromhout, H., Nijssen, P., Huss, A., and Vermeulen, R. (2012). Is pesticide use related to Parkinson disease? Some clues to heterogeneity in study results. Environ. Health Perspect. 120, 340-347. doi: 10.1289/ehp.1103881
230. Verina, T., Kiihl, S. F., Schneider, J. S., and Guilarte, T. R. (2011). Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. Neurotoxicology 32, 215-226. doi: 10.1016/j.neuro.2010.11.003
231. Wagner, S. R., and Greene, F. E. (1978). Dieldrin-induced alterations in biogenic amine content of rat brain. Toxicol. Appl. Pharmacol. 43, 45-55. doi: 10.1016/s0041-008x(78)80031-3
232. Walton, J. R., and Wang, M. X. (2009). APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer's disease. J. Inorg. Biochem. 103, 1548-1554. doi: 10.1016/j.jinorgbio.2009.07.027
233. Wang, A., Costello, S., Cockburn, M., Zhang, X., Bronstein, J., and Ritz, B. (2011). Parkinson's disease risk from ambient exposure to pesticides. Eur. J. Epidemiol. 26, 547-555. doi: 10.1007/s10654-011-9574-5
234. Wang, B., and Du, Y. (2013). Cadmium and its neurotoxic effects. Oxid. Med. Cell. Longev. 2013:898034. doi: 10.1155/2013/898034
235. Wang, J. D., Huang, C. C., Hwang, Y. H., Chiang, J. R., Lin, J. M., and Chen, J. S. (1989). Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br. J. Ind. Med. 46, 856-859. doi: 10.1136/oem.46.12.856
236. Wang, C., Ko, H. S., Thomas, B., Tsang, F., Chew, K. C., Tay, S. P., et al. (2005). Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function. Hum. Mol. Genet. 14, 3885-3897. doi: 10.1093/hmg/ddi413
237. Wang, Y., Wang, X., Li, R., Yang, Z. F., Wang, Y. Z., Gong, X. L., et al. (2013). A DNA methyltransferase inhibitor, 5-aza-2′-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson's disease-related genes in dopaminergic neurons. CNS Neurosci. Ther. 19, 183-190. doi: 10.1111/cns.12059
238. Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., et al. (2001). A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414, 212-216. doi: 10.1038/35102591
239. Weisskopf, M. G., Knekt, P., O'reilly, E. J., Lyytinen, J., Reunanen, A., Laden, F., et al. (2010a). Persistent organochlorine pesticides in serum and risk of Parkinson disease. Neurology 74, 1055-1061. doi: 10.1212/WNL.0b013e3181d76a93
240. Weisskopf, M. G., Weuve, J., Nie, H., Saint-Hilaire, M. H., Sudarsky, L., Simon, D. K., et al. (2010b). Association of cumulative lead exposure with Parkinson's disease. Environ. Health Perspect. 118, 1609-1613. doi: 10.1289/ehp.1002339
241. Weitzman, S. A., Turk, P. W., Milkowski, D. H., and Kozlowski, K. (1994). Free radical adducts induce alterations in DNA cytosine methylation. Proc. Natl. Acad. Sci. U S A 91, 1261-1264. doi: 10.1073/pnas.91.4.1261
242. Wenstrup, D., Ehmann, W. D., and Markesbery, W. R. (1990). Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains. Brain Res. 533, 125-131. doi: 10.1016/0006-8993(90)91804-p
243. Wille, H., Drewes, G., Biernat, J., Mandelkow, E. M., and Mandelkow, E. (1992). Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J. Cell Biol. 118, 573-584. doi: 10.1083/jcb.118.3.573
244. Wills, J., Credle, J., Oaks, A. W., Duka, V., Lee, J. H., Jones, J., et al. (2012). Paraquat, but not maneb, induces synucleinopathy and tauopathy in striata of mice through inhibition of proteasomal and autophagic pathways. PLoS One 7:e30745. doi: 10.1371/journal.pone.0030745
245. Wirdefeldt, K., Adami, H. O., Cole, P., Trichopoulos, D., and Mandel, J. (2011). Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur. J. Epidemiol. 26(Suppl. 1), S1-S58. doi: 10.1007/s10654-011-9581-6
246. Wojcik, D. P., Godfrey, M. E., Christie, D., and Haley, B. E. (2006). Mercury toxicity presenting as chronic fatigue, memory impairment and depression: diagnosis, treatment, susceptibility and outcomes in a New Zealand general practice setting(1994-2006). Neuro. Endocrinol. Lett. 27, 415-423.
247. Wu, J., Basha, M. R., Brock, B., Cox, D. P., Cardozo-Pelaez, F., Mcpherson, C. A., et al. (2008). Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J. Neurosci. 28, 3-9. doi: 10.1523/jneurosci.4405-07.2008
248. Wu, X. F., Block, M. L., Zhang, W., Qin, L., Wilson, B., Zhang, W. Q., et al. (2005). The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxid. Redox Signal. 7, 654-661. doi: 10.1089/ars.2005.7.654
249. Wu, J., Wang, C., Sun, J., and Xue, Y. (2011). Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways. ACS Nano 5, 4476-4489. doi: 10.1021/nn103530b
250. Wu, J., and Xie, H. (2014). Effects of titanium dioxide nanoparticles on alpha-synuclein aggregation and the ubiquitin-proteasome system in dopaminergic neurons. Artif. Cells Nanomed. Biotechnol. 1-5. doi: 10.3109/21691401.2014.980507. [Epub ahead of print].
251. Wypijewska, A., Galazka-Friedman, J., Bauminger, E. R., Wszolek, Z. K., Schweitzer, K. J., Dickson, D. W., et al. (2010). Iron and reactive oxygen species activity in parkinsonian substantia nigra. Parkinsonism Relat. Disord. 16, 329-333. doi: 10.1016/j.parkreldis.2010.02.007
252. Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., et al. (2003). Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 9, 453-457. doi: 10.1038/nm838
253. Yamamoto, H., Saitoh, Y., Yasugawa, S., and Miyamoto, E. (1990). Dephosphorylation of tau factor by protein phosphatase 2A in synaptosomal cytosol fractions and inhibition by aluminum. J. Neurochem. 55, 683-690. doi: 10.1111/j.1471-4159.1990.tb04187.x
254. Yamin, G., Glaser, C. B., Uversky, V. N., and Fink, A. L. (2003). Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein. J. Biol. Chem. 278, 27630-27635. doi: 10.1074/jbc.m303302200
255. Yang, X., He, C., Li, J., Chen, H., Ma, Q., Sui, X., et al. (2014). Uptake of silica nanoparticles: neurotoxicity and Alzheimer-like pathology in human SK-N-SH and mouse neuro2a neuroblastoma cells. Toxicol. Lett. 229, 240-249. doi: 10.1016/j.toxlet.2014.05.009
256. Yang, D. J., Shi, S., Zheng, L. F., Yao, T. M., and Ji, L. N. (2010). Mercury(II) promotes the in vitro aggregation of tau fragment corresponding to the second repeat of microtubule-binding domain: coordination and conformational transition. Biopolymers 93, 1100-1107. doi: 10.1002/bip.21527
257. Yang, W., and Tiffany-Castiglioni, E. (2007). The bipyridyl herbicide paraquat induces proteasome dysfunction in human neuroblastoma SH-SY5Y cells. J. Toxicol. Environ. Health A 70, 1849-1857. doi: 10.1080/15287390701459262
258. Zarazúa, S., Bürger, S., Delgado, J. M., Jiménez-Capdeville, M. E., and Schliebs, R. (2011). Arsenic affects expression and processing of amyloid precursor protein (APP) in primary neuronal cells overexpressing the Swedish mutation of human APP. Int. J. Dev. Neurosci. 29, 389-396. doi: 10.1016/j.ijdevneu.2011.03.004
259. Zawia, N. H., Lahiri, D. K., and Cardozo-Pelaez, F. (2009). Epigenetics, oxidative stress and Alzheimer disease. Free Radic. Biol. Med. 46, 1241-1249. doi: 10.1016/j.freeradbiomed.2009.02.006
260. Ze, Y., Hu, R., Wang, X., Sang, X., Ze, X., Li, B., et al. (2014). Neurotoxicity and gene-expressed profile in brain-injured mice caused by exposure to titanium dioxide nanoparticles. J. Biomed. Mater. Res. A 102, 470-478. doi: 10.1002/jbm.a.34705
261. Zecca, L., Tampellini, D., Gatti, A., Crippa, R., Eisner, M., Sulzer, D., et al. (2002). The neuromelanin of human substantia nigra and its interaction with metals. J. Neural Transm. 109, 663-672. doi: 10.1007/s007020200055
262. Zecca, L., Youdim, M. B., Riederer, P., Connor, J. R., and Crichton, R. R. (2004). Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863-873. doi: 10.1038/nrn1537
263. Zhang, J., Cai, T., Zhao, F., Yao, T., Chen, Y., Liu, X., et al. (2012). The role of alpha-synuclein and tau hyperphosphorylation-mediated autophagy and apoptosis in lead-induced learning and memory injury. Int. J. Biol. Sci. 8, 935-944. doi: 10.7150/ijbs.4499
264. Zhao, Y., Bhattacharjee, S., Jones, B. M., Hill, J., Dua, P., and Lukiw, W. J. (2014). Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells. Mol. Neurobiol. 50, 97-106. doi: 10.1007/s12035-013-8595-3
265. Zheng, W., and Monnot, A. D. (2012). Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases. Pharmacol. Ther. 133, 177-188. doi: 10.1016/j.pharmthera.2011.10.006
266. Zlokovic, B. V., Deane, R., Sagare, A. P., Bell, R. D., and Winkler, E. A. (2010). Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid beta-peptide elimination from the brain. J. Neurochem. 115, 1077-1089. doi: 10.1111/j.1471-4159.2010.07002.x